ACTRN12605000423617已完成1 期
Phase I trial of the safety and the effect on immune parameters of an immunotherapy for glioma based on cultured autologous dendritic cells presenting autologous tumour cell antigens derived from irradiated glioma cells
Queensland Institute of Medical Research (QIMR)0 个研究点目标入组 10 人开始时间: 2005年9月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 1 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Confirmed Malignant Glioma, Macroscopic tumour resection, normal haematolological parameters, acceptable liver and renal function parameters.
排除标准
- •Extensive intracranial disease precluding total or subtotal resection, ECOG status >2, History of autoimmune disease or immunosuppressive therapy, Prior use of immunotherapeutic agent, Positive serology for HIV, Hep B or Hep C, Significant non-malignant disease, Pregnancy, Other malignancy, Patients in whom only biopsy or partial resection was possible.
研究者
相似试验
已完成
1 期
A Phase I clinical trial to assess safety and immune response of Influenza vaccine of Serum Institute of India Limited in Adults.CTRI/2011/09/002033Serum Institute of India Ltd Pune India40
进行中（未招募）
1 期
A study of a new vaccine against the MERS virus in adults aged 50 to 70 yearsMiddle East Respiratory Syndrome Coronavirus (MERS-CoV) infectionInfections and InfestationsISRCTN17936606niversity of Oxford84
已完成
1 期
Safety and immunogenicity of a new tuberculosis (TB) vaccine (MVA85A) in healthy volunteers in Cape TowTuberculosisISRCTN17498868niversity of Oxford (UK)36
尚未招募
不适用
Malaria vectored vaccines and EPI co-administration trial (VAC 058)MalariaPACTR201402000749217THE JENNER INSTITUTE, UNIVERSITY OF OXFORD65
进行中（未招募）
1 期
Investigating a vaccine against plaguePlagueInfections and InfestationsISRCTN41077863niversity of Oxford36